Product Name | MF | CAS | Details |
---|
4-(benzo[b]thiophen-4-yl)-1-(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butyl)piperazine 1-oxide | C25H27N3O3S | 1191900-58-9 | Details |
1-(benzo[b]thiophen-4-yl)-4-(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butyl)piperazine 1,4-dioxide | C25H27N3O4S | 2247155-42-4 | Details |
6-bromo-4-chloro-7-fluoro-3-nitroquinoline | C9H3BrClFN2O2 | 853908-81-3 | Details |
7-(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butoxy)-1-(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butyl)quinolin-2(1H)-one | Details |
7-(4-((7-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2-yl)oxy)butoxy)quinolin-2(1H)-one | C38H40N4O4S | 2116542-21-1 | Details |
7,7'-(((quinoline-2,7-diylbis(oxy))bis(butane-4,1-diyl))bis(oxy))bis(quinolin-2(1H)-one) | Details |
6-methyl-4-oxohept-5-enoic acid | C8H12O3 | 54608-07-0 | Details |
tert-butyl ((2R,3S)-2-(2,5-difluorophenyl)-5-oxotetrahydro-2H-pyran-3-yl)carbamate | C16H19F2NO4 | 951127-25-6 | Details |
4-(1H-Tetrazol-1-yl)benzenamine | C7H7N5 | 14213-13-9 | Details |
2-(4-(2-morpholinoethoxy)naphthalen-1-yl)-2-oxoacetic acid | C18H19NO5 | 1023991-14-1 | Details |
methyl 5-cyanothiophene-2-carboxylate | C7H5NO2S | 67808-34-8 | Details |
4-(2-nitro-5-(piperazin-1-yl)phenyl)morpholine | C14H20N4O3 | 332023-13-9 | Details |
7-chloro-8-fluoro-4-hydroxy-1,6-naphthyridin-2(1H)-one | C8H4ClFN2O2 | 2763157-75-9 | Details |
1-(4-(4-amino-3-morpholinophenyl)piperazin-1-yl)ethan-1-one | C16H12Cl2N2O2 | 60771-18-8 | Details |
GDC6036 | C29H32ClF4N7O2 | 2417987-45-0 | Details |
MRTX-EX185 | Details |
2-chloro-4-morpholinothieno[3,2-d]pyrimidine-6-carbaldehyde | C11H10ClN3O2S | 885618-31-5 | Details |
CNX-1351 | C30H35N7O3S | 1276105-89-5 | Details |
3-fluorobenzyl methanesulfonate | C8H9FO3S | 1000370-26-2 | Details |
1-(p-tolyl)-1H-tetrazole-5-thiol | C8H8N4S | Details |
PF-06679142 | C20H17F2NO3 | 1467059-66-0 | Details |
Famotidine | C8H15N7O2S3 | 76824-35-6 | Details |
5-bromo-1,3-dichloroisoquinoline | C9H4BrCl2N | 1215767-89-7 | Details |
ARRY-380 | C29H27N7O4S | 937265-83-3 | Details |
TEPP46; ML265 | C17H16N4O2S2 | 1221186-53-3 | Details |
2-(Methylsulfonyl)-2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole | C12H15N3O5S2 | 1280210-80-1 | Details |
Sovilnesib | C26H34F2N6O4S | 2410796-79-9 | Details |
2-(4-bromo-2,6-dimethylphenyl)acetonitrile | C10H10BrN | 205035-09-2 | Details |
6-azaspiro[2.5]octane hydrochloride | C7H14ClN | 1037834-62-0 | Details |
MRTX1133 | C33H31F3N6O2 | 2621928-55-8 | Details |
5-methyl-N-(4-sulfamoylphenethyl)pyrazine-2-carboxamide | C14H16N4O3S | 33288-71-0 | Details |
UNC6934 | C24H21N5O4 | 2561494-77-5 | Details |
GDC0879 | C19H18N4O2 | 905281-76-7 | Details |
3-Ethynyl-3-Hydroxy-1-Methylpyrrolidin-2-One | C7H9NO2 | 1202769-93-4 | Details |
PZ-II-029 | C18H15N3O3 | 164025-44-9 | Details |
NIK SMI1 | C20H19N3O4 | 1660114-31-7 | Details |
DAC51 | C18H16Cl2N4O2 | 2243944-92-3 | Details |
Y-33075 HCl | C16H18Cl2N4O | 173897-44-4 | Details |
GDC0980 | C23H30N8O3S | 1032754-93-0 | Details |
BRD4 Inhibitor-10 | C25H27N5O2 | 1660117-38-3 | Details |
RBN-012759 | C19H23FN2O3S | 2360851-29-0 | Details |
BOS 318 | C28H32Cl2N6O3 | 2387633-15-8 | Details |
AP-III-a4 | C31H43FN8O3 | 1177827-73-4 | Details |
NVP-TNKS656 | C27H34N4O5 | 1419949-20-4 | Details |
(R)-3-ethynyl-3-hydroxy-1-methylpyrrolidin-2-one(WX191384) | C7H9NO2 | 1451089-77-2 | Details |
MK8745 | C20H19ClFN5OS | 885325-71-3 | Details |
Pan-RAS-IN-1 | C36H41Cl2F3N6O2 | 1835283-94-7 | Details |
RBN-2397 | C20H23F6N7O3 | 2381037-82-5 | Details |
2-Pyridinamine, 6-bromo-4-methyl-5-(trifluoromethyl)- | C7H6BrF3N2 | 2417920-98-8 | Details |
Famotidine EP Impurity F | C8H12N4O2S2 | 107880-74-0 | Details |
(S)-3-ethynyl-3-hydroxy-1-methylpyrrolidin-2-one(WX191385) | C7H9NO2 | 1799615-79-4 | Details |
RBN-3143 | C22H28FN3O4S | 2360853-16-1 | Details |
3-CHLORO-5-NITROISOQUINOLINE | C9H5ClN2O2 | 10296-47-6 | Details |
(S)-Remoxipride Hydrochloride | C16H24BrClN2O3 | 73220-03-8 | Details |
KPT-9294 | C35H29F3N4O3 | 1643913-93-2 | Details |
GSK2837808A | C31H25F2N5O7S | 1445879-21-9 | Details |
SLx-4090 | C31H25F3N2O4 | 913541-47-6 | Details |
SMBA 1 | C20H13NO3 | 906440-37-7 | Details |
FB23-2 | C18H15Cl2N3O3 | 2243736-45-8 | Details |
RBN-013209 | C19H24N6O3 | 2597933-17-8 | Details |
ethyl 3-(((2-((diaminomethylene)amino)thiazol-4-yl)methyl)thio)propanoate | C8H15N7O2S3 | 88061-72-7 | Details |
SCH 529074 | C31H36Cl2N6 | 922150-11-6 | Details |
ethyl (4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)carbamate | C18H27N3O5S | 13554-93-3 | Details |
5-(3-chloro-2-hydroxypropoxy)-3,4-dihydroquinolin-2(1H)-one | C12H14ClNO3 | 51781-13-6 | Details |
5-(2,3-dihydroxypropoxy)-3,4-dihydroquinolin-2(1H)-one | C12H15NO4 | 54945-72-1 | Details |
2,7-bis(4-chlorobutoxy)quinoline | C17H21Cl2NO2 | 2060027-95-2 | Details |
7-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butyl)quinolin-2(1H)-one | C38H40N4O4S | 2094559-58-5 | Details |
Famotidine EP Impurity C HCl | C8H15ClN6O3S3 | 76824-17-4 | Details |
Famotidine EP Impurity B | C16H23N11O2S5 | 89268-62-2 | Details |
Famotidine EP Impurity I HCl | C8H14N6O4S3 | 1020719-36-1 | Details |
Famotidine EP Impurity E | C10H14N8S4 | 129083-44-9 | Details |
5-(oxiran-2-ylmethoxy)-3,4-dihydroquinolin-2(1H)-one | C12H13NO3 | 51781-14-7 | Details |
4-(2-(3-cyclohexylureido)ethyl)benzenesulfonamide | C15H23N3O3S | 10080-05-4 | Details |
Famotidine EP Impurity H di HCl | C6H11ClN6S2 | 88046-01-9 | Details |
4-chloro-7-methoxy-N,N-dimethylquinoline-6-carboxamide | C13H13ClN2O2 | 417723-66-1 | Details |
4-(4-amino-3-chlorophenoxy)-7-methoxyquinoline-6-carboxylic acid | C17H13ClN2O4 | 2712290-12-3 | Details |
5-hydroxy-3,4-dihydroquinolin-2(1H)-one | C9H9NO2 | 30389-33-4 | Details |
7,7'-(butane-1,4-diylbis(oxy))bis(quinolin-2(1H)-one) | C22H20N2O4 | 2116542-19-7 | Details |
5-(2-hydroxy-3-methoxypropoxy)-3,4-dihydroquinolin-2(1H)-one | C13H17NO4 | 2748462-60-2 | Details |
N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-6-methylpyrazine-2-carboxamide | C21H27N5O4S | 66375-96-0 | Details |
methyl ((4-(2-(5-methylpyrazine-2-carboxamido)ethyl)phenyl)sulfonyl)carbamate | C16H18N4O5S | 33288-74-3 | Details |
4-chloro-7-methoxyquinoline-6-carboxylic acid | C11H8ClNO3 | 771464-30-3 | Details |
4-(((2S,3R,4S,5R,6R)-3,4,5-triacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl)oxy)benzoic acid | C21H24O12 | 76306-75-7 | Details |
(2R,3S,4S,5R,6S)-2-(acetoxymethyl)-6-(4-formylphenoxy)-4-hydroxytetrahydro-2H-pyran-3,5-diyl diacetate | Details |
Famotidine Impurity K | C8H15N7O3S3 | 90237-03-9 | Details |
1,4-bis(benzo[b]thiophen-4-yl)piperazine | C20H18N2S2 | 1420987-86-5 | Details |
7-(4-chlorobutoxy)-1-(4-chlorobutyl)quinolin-2(1H)-one | C17H21Cl2NO2 | 2059954-32-2 | Details |
2,7-bis(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinoline | C41H47N5O2S2 | 2138169-93-2 | Details |
2-(4-(((2-cyanoethyl)thio)methyl)thiazol-2-yl)guanidine | C9H16ClN5OS2 | 1797843-63-0 | Details |
methyl 4-(4-amino-3-chlorophenoxy)-7-methoxyquinoline-6-carboxylate | C18H15ClN2O4 | 417723-07-0 | Details |
(2R,3R,4S,5R,6S)-2-(acetoxymethyl)-6-(4-formylphenoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate | C21H24O11 | 31873-42-4 | Details |
Famotidine EP Impurity G | C9H13N7S2 | 76823-97-7 | Details |
Famotidine EP Impurity A HCl | C8H15ClN6S2 | 76833-47-1 | Details |
N-(cyclohexylcarbamoyl)-4-(2-(3-cyclohexylureido)ethyl)benzenesulfonamide | C22H34N4O4S | 10079-35-3 | Details |
Famotidine EP Impurity J | C9H14N4O2S2 | 76824-14-1 | Details |
5,5'-((2-hydroxypropane-1,3-diyl)bis(oxy))bis(3,4-dihydroquinolin-2(1H)-one) | C21H22N2O5 | 56660-90-3 | Details |
methyl ((4-(2-(5-chloro-2-methoxybenzamido)ethyl)phenyl)sulfonyl)carbamate | C18H19ClN2O6S | 21165-77-5 | Details |
Famotidine EP Impurity D | C8H13N5OS2 | 76824-16-3 | Details |
ethyl (4-sulfamoylphenethyl)carbamate | C11H16N2O4S | 192118-08-4 | Details |
7-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butyl)quinolin-2(1H)-one | C41H47N5O2S2 | 2137823-20-0 | Details |
Product Total: Product Page: | ||||
1 2 |